1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Genix Pharmaceuticals Corporation
  6. Financials
    GENX   CA37232A1093

GENIX PHARMACEUTICALS CORPORATION

(GENX)
Delayed Bourse de Toronto  -  05/18 11:32:34 am EDT
0.1400 CAD    0.00%
04/27GENIX PHARMACEUTICALS : - Form of Proxy
PU
04/27GENIX PHARMACEUTICALS : - Notice and Information Circular
PU
03/25Genix Pharmaceuticals Corporation Reports Earnings Results for the First Quarter Ended January 31, 2022
CI
SummaryQuotesChartsNewsCalendarCompanyFinancials 
Valuation
Fiscal Period: October 2016 2017 2018 2019 2020 2021
Capitalization1 1,501,132,442,639,808,88
Enterprise Value (EV)1 1,391,022,372,629,128,79
P/E ratio -10,3x-4,63x18,2x-15,9x-11,5x-5,38x
Yield ------
Capitalization / Revenue 1,62x2,67x5,81x19,1x--
EV / Revenue 1,50x2,43x5,64x19,0x--
EV / EBITDA -14,8x-17,9x-98,9x-21,3x-28,7x-8,05x
Price to Book 4,07x9,31x19,9x-62,3x2,01x2,21x
Nbr of stocks (in thousands) 37 51437 51437 51437 51459 40959 224
Reference price (CAD) 0,040,030,070,070,170,15
Announcement Date 02/28/201803/01/201902/27/202003/01/202102/28/202202/28/2022
1 CAD in Million
Income Statement Evolution (Annual data)
Fiscal Period: October 2016 2017 2018 2019 2020 2021
Net sales1 0,920,420,420,14--
EBITDA1 -0,09-0,06-0,02-0,12-0,32-1,09
Operating profit (EBIT)1 -0,14-0,06-0,02-0,12-0,68-1,61
Operating Margin -15,1%-13,6%-5,73%-89,7%--
Pre-Tax Profit (EBT)1 -0,15-0,03-0,03-0,16-0,72-1,65
Net income1 -0,15-0,240,13-0,16-0,72-1,65
Net margin -15,7%-57,7%31,9%-120%--
EPS2 0,00-0,010,000,00-0,01-0,03
Dividend per Share ------
Announcement Date 02/28/201803/01/201902/27/202003/01/202102/28/202202/28/2022
1 CAD in Million
2 CAD
Balance Sheet Analysis
Fiscal Period: October 2016 2017 2018 2019 2020 2021
Net Debt1 ------
Net Cash position1 0,110,100,070,010,680,09
Leverage (Debt / EBITDA) 1,19x1,76x2,92x0,09x2,15x0,08x
Free Cash Flow1 -0,100,15-0,150,030,290,68
ROE (Net Profit / Equities) -33,1%-12,4%-20,7%-410%-29,8%-37,3%
Shareholders' equity1 0,441,97-0,650,042,414,44
ROA (Net Profit / Asset) -16,3%-8,50%-4,81%-56,6%-15,7%-20,0%
Assets1 0,892,86-2,790,294,568,28
Book Value Per Share2 0,010,000,000,000,080,07
Cash Flow per Share2 0,000,000,000,000,010,00
Capex ------
Capex / Sales ------
Announcement Date 02/28/201803/01/201902/27/202003/01/202102/28/202202/28/2022
1 CAD in Million
2 CAD
Key data
Capitalization (CAD) 8 291 378
Capitalization (USD) 6 456 806
Free-Float 55,5%
Free-Float capitalization (CAD) 4 600 261
Free-Float capitalization (USD) 3 582 395
Avg. Exchange 20 sessions () 340
Avg. Exchange 20 sessions (USD) 0,00
Average Daily Capital Traded 0,00%
EPS & Dividend